Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab with or without Oxaliplatin, Fluorouracil, and Leucovorin in Advanced Colorectal Cancer
NCT00025337Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2001
- Primary completion
- Apr 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in colorectal cancer (CRC), sponsored by National Cancer Institute. Started Sep 2001; status: completed.
02
Drugs
bevacizumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00025337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00025337.